Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Meeran, Syed M ^a,b   Patel, Shweta N ^b   Li, Yuanyuan ^b   Shukla, Samriddhi ^a   Tollefsbol, Trygve O ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; POLYPHENOL; SULFORAPHANE; TAMOXIFEN;

ACETYLATION; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMATION MODIFICATION; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DNA DETERMINATION; DNA METHYLATION; HUMAN; HUMAN CELL; HYPERACETYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REPRESSOR GENE; TEA; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; DIETARY SUPPLEMENTS; DNA METHYLATION; DRUG SYNERGISM; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; PLANT EXTRACTS; POLYPHENOLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TEA; THIOCYANATES; TRANSCRIPTION FACTORS;

EID: 84861470752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037748     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin. United States pp. 69-90.
2. Saxena NK, Sharma D, (2010) Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy. Mol Cell Pharmacol 2: 191-202.
3. Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, et al. (2011) Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell 20: 119-131.
4. Li Y, Yuan YY, Meeran SM, Tollefsbol TO, (2010) Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells. Mol Cancer 9: 274.
5. Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, et al. (1995) Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 87: 446-451.
6. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, et al. (1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56: 973-977.
7. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, et al. (2005) Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol 19: 1740-1751.
8. Macaluso M, Cinti C, Russo G, Russo A, Giordano A, (2003) pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene 22: 3511-3517.
9. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, et al. (2001) Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61: 7025-7029.
10. Jang ER, Lim SJ, Lee ES, Jeong G, Kim TY, et al. (2004) The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene 23: 1724-1736.
11. Cheung KL, Kong AN, (2010) Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12: 87-97.
12. Mukhtar H, Ahmad N, (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71: 1698S-1702S; discussion 1703S-1694S.
13. Fang M, Wang Y, Ai N, Hou Z, Sun Y, et al. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570.
14. Fang M, Chen D, Yang C, (2007) Dietary polyphenols may affect DNA methylation. J Nutr 137: 223S-228S.
15. Nandakumar V, Vaid M, Katiyar SK, (2011) (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32: 537-544.
16. Myzak MC, Karplus PA, Chung FL, Dashwood RH, (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64: 5767-5774.
17. Nian H, Delage B, Ho E, Dashwood R, (2009) Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 50: 213-221.
18. Meeran SM, Patel SN, Tollefsbol TO, (2010) Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One. 5: e11457.
19. Golubovskaya V, Virnig C, Cance W, (2008) TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. Mol Carcinog 47: 222-234.
20. Ciftci K, Su J, Trovitch P, (2003) Growth factors and chemotherapeutic modulation of breast cancer cells. J Pharm Pharmacol 55: 1135-1141.
21. Meeran SM, Patel SN, Chan TH, Tollefsbol TO, (2011) A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila) 4: 1243-1254.
22. Meeran SM, Mantena SK, Meleth S, Elmets CA, Katiyar SK, (2006) Interleukin-12-deficient mice are at greater risk of UV radiation-induced skin tumors and malignant transformation of papillomas to carcinomas. Mol Cancer Ther 5: 825-832.
23. Meeran SM, Katiyar S, Katiyar SK, (2008) Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229: 33-43.
24. Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, et al. (2009) Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 69: 583-592.
25. Zhou Q, Atadja P, Davidson NE, (2007) Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. Cancer Biol Ther 6: 64-69.
26. Vaute O, Nicolas E, Vandel L, Trouche D, (2002) Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Res 30: 475-481.
27. Lee W, Zhu B, (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27: 269-277.
28. Landis-Piwowar KR, Milacic V, Dou QP, (2008) Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. J Cell Biochem 105: 514-523.
29. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, et al. (2008) Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68: 2736-2744.
30. Graham H, (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21: 334-350.
31. Lin J, Liang Y, (2000) Cancer chemoprevention by tea polyphenols. Proc Natl Sci Counc Repub China B 24: 1-13.
32. Lee W, Shim J, Zhu B, (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68: 1018-1030.
33. Shi L, Sun L, Li Q, Liang J, Yu W, et al. (2011) Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci U S A 108: 7541-7546.
34. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI, (2001) Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292: 110-113.
35. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, et al. (2000) The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19: 1020-1027.
36. Rossi C, Di Lena A, La Sorda R, Lattanzio R, Antolini L, et al. (2008) Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. Eur J Cancer 44: 2696-2704.